UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia

Figure 4

The statistical results of 25 biomarkers. (a, b) Comparison of 7 biomarkers peak relative signal intensities in hyperlipidemia and healthy volunteer. (c-e) Comparison of 18 biomarkers peak relative signal intensities in hyperlipidemia with syndrome of SLQSD and hyperlipidemia with the syndrome of non-SLQSD groups. Values are means ±SD, P<0.05, and P<0.01.

(a)

(b)

(c)

(d)

(e)